Muscle Atrophy - Pipeline Review, H1 2014 @ http://www.researchmoz.us/muscle-atrophy-pipeline-review-h1-2014-report.html This report provides comprehensive information on the therapeutic development for Muscle Atrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

1. Muscle Atrophy - Pipeline Review, H1 2014
Muscle Atrophy - Pipeline Review, H1 2014
Summary
Global Markets Directs, Muscle Atrophy - Pipeline Review, H1 2014, provides an overview of the Muscle Atrophys therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Muscle Atrophy, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in the therapeutic development for Muscle Atrophy and special features on late-stage and
discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global therapeutic landscape of Muscle Atrophy
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration
details & other developmental activities
- The report reviews key players involved in the therapeutics development for Muscle Atrophy and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Muscle Atrophy products under development by companies and universities/research institutes based on information derived from company and
industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Muscle Atrophy pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Muscle Atrophy
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Muscle Atrophy pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand
business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 4
introduction 5
global Markets Direct Report Coverage 5
muscle Atrophy Overview 6
therapeutics Development 7
pipeline Products For Muscle Atrophy - Overview 7
pipeline Products For Muscle Atrophy - Comparative Analysis 8
muscle Atrophy - Therapeutics Under Development By Companies 9
muscle Atrophy - Therapeutics Under Investigation By Universities/institutes 11
muscle Atrophy - Pipeline Products Glance 12
clinical Stage Products 12
early Stage Products 13
Muscle Atrophy - Pipeline Review, H1 2014

2. muscle Atrophy - Products Under Development By Companies 14
muscle Atrophy - Products Under Investigation By Universities/institutes 15
muscle Atrophy - Companies Involved In Therapeutics Development 16
eli Lilly And Company 16
rigel Pharmaceuticals, Inc. 17
fate Therapeutics, Inc. 18
muscle Atrophy - Therapeutics Assessment 19
assessment By Monotherapy Products 19
assessment By Target 20
assessment By Mechanism Of Action 22
assessment By Route Of Administration 24
assessment By Molecule Type 26
drug Profiles 28
ly-2495655 - Drug Profile 28
product Description 28
mechanism Of Action 28
r&d Progress 28
drug For Muscle Atrophy - Drug Profile 29
product Description 29
mechanism Of Action 29
r&d Progress 29
atropy Inhibitor - Drug Profile 30
product Description 30
mechanism Of Action 30
r&d Progress 30
ft-301 - Drug Profile 31
product Description 31
mechanism Of Action 31
r&d Progress 31
wnt7a-based Protein Thearpeutics - Drug Profile 33
product Description 33
mechanism Of Action 33
r&d Progress 33
l-379 - Drug Profile 35
product Description 35
mechanism Of Action 35
r&d Progress 35
muscle Atrophy - Recent Pipeline Updates 36
muscle Atrophy - Dormant Projects 37
appendix 38
methodology 38
coverage 38
secondary Research 38
primary Research 38
expert Panel Validation 38
contact Us 39
disclaimer 39
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Muscle Atrophy - Pipeline Review, H1 2014